PHARMACOM RETAROS – Retatrutide Compound Peptide -15 MG / VIAL -2 ML

PHARMACOM RETAROS – Retatrutide Compound Peptide

Strength: 15mg / Vial
Volume: 2ml

Product Description

PHARMACOM RETAROS contains Retatrutide, an innovative triple-receptor agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. This next-generation compound is being studied for its potential effects on appetite regulation, metabolic function, energy expenditure, and weight management. Unlike earlier peptides that target one or two pathways, Retatrutide's triple-action mechanism offers a comprehensive approach to metabolic support.

RETAROS is designed for individuals seeking advanced metabolic support and may assist with appetite control, improved energy utilization, and overall weight-management goals when combined with a healthy lifestyle.

Key Benefits

✅ Advanced triple-action peptide targeting GLP-1, GIP, and glucagon receptors.

✅ May help reduce appetite and support portion control.

✅ Supports healthy weight-management goals as part of a balanced lifestyle.

✅ May assist with metabolic efficiency and energy expenditure.

✅ Supports healthy blood glucose regulation through multiple metabolic pathways.

Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.

Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.